Big Pharma’s $1Bn Antibiotic Development Fund Offers ‘Breathing Room’ For Reimbursement Fix

 
• By Brenda Sandburg

Companies developing antibiotics to get financial and technical support from more than 20 firms contributing to new AMR Action Fund. Initiative is also pushing for reimbursement reform and other policies to support commercial marketing.

AMR Action Fund Launch CEOs
Big pharma is providing $1bn to support antibiotic clinical research • Source: Screen shot of AMR Action Fund launch

More from Anti-infective

More from Therapy Areas